Sustained-Release Injectable Products focuses on the development process for sustained-release versions of drugs and delivery systems and administration.
We aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Case numbers are resurging in parts of the world where the COVID-19 pandemic was waning, falling in places that saw huge surges recently, and just beginning to rise in previously little-impacted parts of the globe.
Studying and analyzing the impact of Coronavirus COVID-19 on the Sustained Release Injectables industry, the report provide in-depth analysis and professtional advices on how to face the post COIVD-19 period.
Market Segment by Product Type
Naltrexone
Exenatide
Estradiol
Other
Market Segment by Product Application
Diabetes
Leukemia
Acromegaly
Other
Finally, the report provides detailed profile and data information analysis of leading company.
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Ascendis Pharma
Taiwan Liposome Company
Insights and Tools:
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
Product values and regional markets are estimated by market analyst, data analyst and people from related industry, based on companys' revenue and applications market respectively.
The data sources include but not limited to reports of companys,international organizations and governments, MMI market surveys,and related industry news.
Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2027
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
In addition, the report provides insight into main drivers,challenges,opportunities and risk of the market and strategies of suppliers. Key players are profiled as well with their market shares in the global market discussed.
Research Objectives
1.To study and analyze the global Sustained Release Injectables consumption (value) by key regions/countries, product type and application, history data from 2017 to 2021, and forecast to 2027.
2.To understand the structure of Sustained Release Injectables market by identifying its various subsegments.
3.Focuses on the key global Sustained Release Injectables manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
4.To analyze the Sustained Release Injectables with respect to individual growth trends, future prospects, and their contribution to the total market.
5.To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
6.To project the consumption of Sustained Release Injectables submarkets, with respect to key regions (along with their respective key countries).
7.To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
8.To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
Global Sustained Release Injectables Market Research Report 2022, Forecast to 2027
1 Market Study Overview
1.1 Study Objectives
1.2 Sustained Release Injectables Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Sustained Release Injectables Segment by Type
2.1.1 Naltrexone
2.1.2 Exenatide
2.1.3 Estradiol
2.1.4 Other
2.2 Market Analysis by Application
2.2.1 Diabetes
2.2.2 Leukemia
2.2.3 Acromegaly
2.2.4 Other
2.3 Global Sustained Release Injectables Market Comparison by Regions (2017-2027)
2.3.1 Global Sustained Release Injectables Market Size (2017-2027)
2.3.2 North America Sustained Release Injectables Status and Prospect (2017-2027)
2.3.3 Europe Sustained Release Injectables Status and Prospect (2017-2027)
2.3.4 China Sustained Release Injectables Status and Prospect (2017-2027)
2.3.5 Japan Sustained Release Injectables Status and Prospect (2017-2027)
2.3.6 Southeast Asia Sustained Release Injectables Status and Prospect (2017-2027)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2019 (Covid-19): Sustained Release Injectables Industry Impact
2.5.1 Sustained Release Injectables Business Impact Assessment - Covid-19
2.5.2 Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Sustained Release Injectables Sales and Market Share by Manufacturer (2017-2022)
3.2 Global Sustained Release Injectables Revenue and Market Share by Manufacturer (2017-2022)
3.3 Global Sustained Release Injectables Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Sustained Release Injectables Manufacturer Market Share
3.5 Top 10 Sustained Release Injectables Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Sustained Release Injectables Market
3.7 Key Manufacturers Sustained Release Injectables Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Sustained Release Injectables Industry Key Manufacturers
4.1 AstraZeneca
4.1.1 Compan Detail
4.1.2 AstraZeneca Sustained Release Injectables Product Introduction, Application and Specification
4.1.3 AstraZeneca 164 Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.1.4 Main Business Overview
4.1.5 AstraZeneca News
4.2 Eli Lilly
4.2.1 Compan Detail
4.2.2 Eli Lilly Sustained Release Injectables Product Introduction, Application and Specification
4.2.3 Eli Lilly Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.2.4 Main Business Overview
4.2.5 AstraZeneca News
4.3 Sanofi
4.3.1 Compan Detail
4.3.2 Sanofi Sustained Release Injectables Product Introduction, Application and Specification
4.3.3 Sanofi Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.3.4 Main Business Overview
4.3.5 Sanofi News
4.4 Roche
4.4.1 Compan Detail
4.4.2 Roche Sustained Release Injectables Product Introduction, Application and Specification
4.4.3 Roche Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.4.4 Main Business Overview
4.4.5 Roche News
4.5 Novartis
4.5.1 Compan Detail
4.5.2 Roche Sustained Release Injectables Product Introduction, Application and Specification
4.5.3 Novartis Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.5.4 Main Business Overview
4.5.5 Novartis News
4.6 Aurobindo
4.6.1 Compan Detail
4.6.2 Aurobindo Sustained Release Injectables Product Introduction, Application and Specification
4.6.3 Aurobindo Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.6.4 Main Business Overview
4.6.5 Aurobindo News
4.7 Avadel
4.7.1 Compan Detail
4.7.2 Avadel Sustained Release Injectables Product Introduction, Application and Specification
4.7.3 Avadel Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
4.8 Biomarin
4.8.1 Compan Detail
4.8.2 Biomarin Sustained Release Injectables Product Introduction, Application and Specification
4.8.3 Biomarin Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.8.4 Main Business Overview
4.8.5 Biomarin News
4.9 Camurus
4.9.1 Compan Detail
4.9.2 Camurus Sustained Release Injectables Product Introduction, Application and Specification
4.9.3 Camurus Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.9.4 Main Business Overview
4.9.5 Camurus News
4.10 Critical Pharmaceuticals
4.10.1 Compan Detail
4.10.2 Critical Pharmaceuticals Sustained Release Injectables Product Introduction, Application and Specification
4.10.3 Critical Pharmaceuticals Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.10.4 Main Business Overview
4.10.5 Critical Pharmaceuticals News
4.11 Alkermes
4.11.1 Compan Detail
4.11.2 Alkermes Sustained Release Injectables Product Introduction, Application and Specification
4.11.3 Alkermes Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.11.4 Main Business Overview
4.11.5 Alkermes News
4.12 Amylin
4.12.1 Compan Detail
4.12.2 Amylin Sustained Release Injectables Product Introduction, Application and Specification
4.12.3 Amylin Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.12.4 Main Business Overview
4.12.5 Amylin News
4.13 Ascendis Pharma
4.13.1 Company Details
4.13.2 Ascendis Pharma Sustained Release Injectables Product Introduction, Application and Specification
4.13.3 Ascendis Pharma Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.13.4 Main Business Overview
4.13.5 Ascendis Pharma News
4.14 Taiwan Liposome Company
4.14.1 Compan Detail
4.14.2 Taiwan Liposome Company Sustained Release Injectables Product Introduction, Application and Specification
4.14.3 Taiwan Liposome Company Sustained Release Injectables Sales, Price, Cost, Gross Margin, and Revenue (2017-2022)
4.14.4 Main Business Overview
4.14.5 Taiwan Liposome Company News
5 Global Sustained Release Injectables Market Segment by Big Type
5.1 Global Sustained Release Injectables Revenue, Sales and Market Share by Big Type (2017-2022)
5.1.1 Global Sustained Release Injectables Sales and Market Share by Big Type (2017-2022)
5.1.2 Global Sustained Release Injectables Revenue and Market Share by Big Type (2017-2022)
5.2 Naltrexone Sales Growth Rate and Price
5.2.1 Global Naltrexone Sales Growth Rate (2017-2022)
5.2.2 Global Naltrexone Price (2017-2022)
5.3 Exenatide Sales Growth Rate and Price
5.3.1 Global Exenatide Sales Growth Rate (2017-2022)
5.3.2 Global Exenatide Price (2017-2022)
5.4 Estradiol Sales Growth Rate and Price
5.4.1 Global Estradiol Sales Growth Rate (2017-2022)
5.4.2 Global Estradiol Price (2017-2022)
5.5 Other Sales Growth Rate and Price
5.5.1 Global Other Sales Growth Rate (2017-2022)
5.5.2 Global Other Price (2017-2022)
6 Global Sustained Release Injectables Market Segment by Big Application
6.1 Global Sustained Release Injectables Sales Market Share by Big Application (2017-2022)
6.2 Diabetes Sales Growth Rate (2017-2022)
6.3 Leukemia Sales Growth Rate (2017-2022)
6.4 Acromegaly Sales Growth Rate (2017-2022)
6.5 Other Sales Growth Rate (2017-2022)
7 Global Sustained Release Injectables Forecast
7.1 Global Sustained Release Injectables Revenue, Sales and Growth Rate (2022-2027)
7.2 Sustained Release Injectables Market Forecast by Regions (2022-2027)
7.2.1 North America Sustained Release Injectables Market Forecast (2022-2027)
7.2.2 Europe Sustained Release Injectables Market Forecast (2022-2027)
7.2.3 China Sustained Release Injectables Market Forecast (2022-2027)
7.2.4 Japan Sustained Release Injectables Market Forecast (2022-2027)
7.2.5 Southeast Asia Sustained Release Injectables Market Forecast (2022-2027)
7.2.6 Other Regions Sustained Release Injectables Market Forecast (2022-2027)
7.3 Sustained Release Injectables Market Forecast by Type (2022-2027)
7.3.1 Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
7.3.2 Global Sustained Release Injectables Market Share Forecast by Type (2022-2027)
7.4 Sustained Release Injectables Market Forecast by Application (2022-2027)
7.4.1 Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
7.4.2 Global Sustained Release Injectables Market Share Forecast by Application (2022-2027)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Sustained Release Injectables Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Sustained Release Injectables Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
List of Tables and Figures
Figure Product Picture Sustained Release Injectables
Figure Market Concentration Ratio and Market Maturity Analysis of Sustained Release Injectables
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Sustained Release Injectables Market Size by Big Type
Figure Global Market Share of Sustained Release Injectables by Big Type in 2021
Figure Naltrexone Picture (2017-2022)
Figure Exenatide Picture (2017-2022)
Figure Estradiol Picture (2017-2022)
Global Sustained Release Injectables Market Size by Big Application
Table Global Sustained Release Injectables Market Size by Application
Figure Global Sustained Release Injectables Market Share by Big Application in 2021
Figure Diabetes Picture
Figure Leukemia Picture
Figure Acromegaly Picture
Figure Other Picture
Table Global Sustained Release Injectables Comparison by Regions (M USD) (2017-2027)
Figure Global Sustained Release Injectables Market Size (Million US$) (2017-2027)
Figure North America Sustained Release Injectables Revenue (Million US$) Growth Rate (2017-2027)
Figure Europe Sustained Release Injectables Revenue (Million US$) Growth Rate (2017-2027)
Figure China Sustained Release Injectables Revenue (Million US$) Growth Rate (2017-2027)
Figure Japan Sustained Release Injectables Revenue (Million US$) Growth Rate (2017-2027)
Figure Southeast Asia Sustained Release Injectables Revenue (Million US$) Growth Rate (2017-2027)
Table Business Impact Assessment - Covid-19
Table Market Trends and Sustained Release Injectables Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Sustained Release Injectables Sales by Manufacturer (2017-2022)
Figure Global Sustained Release Injectables Sales Market Share by Manufacturer in 2021
Table Global Sustained Release Injectables Revenue by Manufacturer (2017-2022)
Figure Global Sustained Release Injectables Revenue Market Share by Manufacturer in 2021
Table Global Sustained Release Injectables Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2021
Figure Top 10 Sustained Release Injectables Manufacturer (Revenue) Market Share in 2021
Table Date of Key Manufacturers Enter into Sustained Release Injectables Market
Table Key Manufacturers Sustained Release Injectables Product Type
Table Mergers & Acquisitions Planning
Table AstraZeneca Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of AstraZeneca
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2017-2022
Table Company One Main Business
Table Company One Recent Development
Table Eli Lilly Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Eli Lilly
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Eli Lilly Recent Development
Table Sanofi Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Sanofi
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Sanofi Main Business
Table Sanofi Recent Development
Table Roche Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Roche
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Roche Main Business
Table Roche Recent Development
Table Roche Main Business
Table Roche Recent Development
Table Novartis Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Novartis
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Novartis Main Business
Table Novartis Recent Development
Table Aurobindo Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Aurobindo
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Aurobindo Main Business
Table Aurobindo Recent Development
Table Avadel Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Avadel
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Avadel Main Business
Table Avadel Recent Development
Table Biomarin Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Biomarin
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Biomarin Main Business
Table Biomarin Recent Development
Table Camurus Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Camurus
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Camurus Main Business
Table Camurus Recent Development
Table Critical Pharmaceuticals Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Critical Pharmaceuticals
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Critical Pharmaceuticals Main Business
Table Critical Pharmaceuticals Recent Development
Table Alkermes Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Alkermes
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Alkermes Main Business
Table Alkermes Recent Development
Table Amylin Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Amylin
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Amylin Main Business
Table Amylin Recent Development
Table Ascendis Pharma Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Ascendis Pharma
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Ascendis Pharma Main Business
Table Ascendis Pharma Recent Development
Table Taiwan Liposome Company Company Profile
Table Sustained Release Injectables Product Introduction, Application and Specification of Taiwan Liposome Company
Table Sustained Release Injectables Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2017-2022
Table Taiwan Liposome Company Main Business
Table Taiwan Liposome Company Recent Development
Figure Global Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure Global Sustained Release Injectables Revenue and Growth Rate (2017-2022)
Table Global Sustained Release Injectables Sales by Regions (2017-2022)
Figure Global Sustained Release Injectables Sales Market Share by Regions in 2021
Table Global Sustained Release Injectables Revenue by Regions (2017-2022)
Figure Global Sustained Release Injectables Revenue Market Share by Regions in 2021
Figure North America Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure Europe Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure China Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure Japan Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure Southeast Asia Sustained Release Injectables Sales and Growth Rate (2017-2022)
Figure Other Regions Sustained Release Injectables Sales and Growth Rate (2017-2022)
Table Global Sustained Release Injectables Sales by Big Type (2017-2022)
Table Global Sustained Release Injectables Sales Market Share by Big Type (2017-2022)
Figure Global Sustained Release Injectables Sales Market Share by Big Type in 2019
Table Global Sustained Release Injectables Revenue by Big Type (2017-2022)
Table Global Sustained Release Injectables Revenue Market Share by Big Type (2017-2022)
Table Global Sustained Release Injectables Revenue Market Share by Big Type in 2019
Figure Global Naltrexone Sales Growth Rate (2017-2022)
Figure Global Naltrexone Price (2017-2022)
Figure Global Exenatide Sales Growth Rate (2017-2022)
Figure Global Exenatide Price (2017-2022)
Figure Global Estradiol Sales Growth Rate (2017-2022)
Figure Global Estradiol Price (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Table Global Sustained Release Injectables Sales by Big Application (2017-2022)
Table Global Sustained Release Injectables Sales Market Share by Big Application (2017-2022)
Figure Global Sustained Release Injectables Sales Market Share by Big Application in 2019
Figure Global Diabetes Sales Growth Rate (2017-2022)
Figure Global Leukemia Sales Growth Rate (2017-2022)
Figure Global Acromegaly Sales Growth Rate (2017-2022)
Figure Global Other Sales Growth Rate (2017-2022)
Figure Global Sustained Release Injectables Sales and Growth Rate (2022-2027)
Figure Global Sustained Release Injectables Revenue and Growth Rate (2022-2027)
Table Global Sustained Release Injectables Sales Forecast by Regions (2022-2027)
Table Global Sustained Release Injectables Market Share Forecast by Regions (2022-2027)
Figure North America Sales Sustained Release Injectables Market Forecast (2022-2027)
Figure Europe Sales Sustained Release Injectables Market Forecast (2022-2027)
Figure China Sales Sustained Release Injectables Market Forecast (2022-2027)
Figure Japan Sales Sustained Release Injectables Market Forecast (2022-2027)
Figure Southeast Asia Sales Sustained Release Injectables Market Forecast (2022-2027)
Figure Other Regions Sales Sustained Release Injectables Market Forecast (2022-2027)
Table Global Sustained Release Injectables Sales Forecast by Type (2022-2027)
Table Global Sustained Release Injectables Market Share Forecast by Type (2022-2027)
Table Global Sustained Release Injectables Sales Forecast by Application (2022-2027)
Table Global Sustained Release Injectables Market Share Forecast by Application (2022-2027)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Sustained Release Injectables
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Sustained Release Injectables Sales (K Units) Growth Rate Forecast (2021-2025)
Figure North America Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Europe Sustained Release Injectables Sales (K Units) Growth Rate Forecast (2021-2025)
Figure Europe Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Japan Sustained Release Injectables Production (K Units) Growth Rate Forecast (2021-2025)
Figure Japan Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure China Sustained Release Injectables Production (K Units) Growth Rate Forecast (2021-2025)
Figure China Sustained Release Injectables Revenue (Million US$) Growth Rate Forecast (2021-2025)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
AstraZeneca
Eli Lilly
Sanofi
Roche
Novartis
Aurobindo
Avadel
Biomarin
Camurus
Critical Pharmaceuticals
Alkermes
Amylin
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)